Drug Development Online Course: Key to Success from Concept to Commercialization - Earn Up to 8 Credits Towards RAC Recertification Upon Full Completion

Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "Drug Development: Key to Success from Concept to Commercialization" training has been added to ResearchAndMarkets.com's offering.

Join Top Drug Development Course To Shape Your Career!

The most successful among all courses for drug development, this course covers the most productive areas. It considers the worldwide market for the pharmaceutical industry along with other significant therapeutic areas. It also takes care of the professionals involved in the pharmaceutical industry. The course includes a wide spectrum of things and objectives that are necessary for everyone who enrols for the best Drug Development Course.

It includes the identification of drug targets and preparation of chemicals used in the making of drugs of various types. Furthermore, the experts take care of the developments in biologics, toxicity examination, clinic tests and examination, pre-clinical development, pharmacokinetics, and also pharmacovigilance. The process, thus, takes care of everything from the discovery of the drugs to post-marketing strategies. The developers involved in the process then explain all necessary aspects of the process of drug development.

Objectives of Learning

  • The construction of controlling submissions
  • How drugs are partitioned for noxiousness
  • Parts of dissimilar medicinal specialists
  • Issues moving oral bioavailability
  • Archetypal costs and timelines related to drug development
  • The evidence obtained at each stage of scientific research
  • How the safety and effectiveness of drug products are protected during QC announcement testing
  • How new drugs are developed against targets in the human body
  • The potential influence of polymorphism, salt form, and isomerism on efficacy and safety
  • Details because drugs fail throughout the growth procedure
  • How formulation can affect drug performance
  • How the manufacture and distribution of drugs are measured

Who Should Attend:

  • Medical and clinical investigators
  • Investigation & expansion scientists
  • Quality Assurance professionals
  • Scientific Research professionals
  • Auditors
  • Strategic planners
  • Senior sales managers
  • Regulatory Affairs Professionals
  • Non-scientific employees of pharmaceutical companies who would like to understand how drugs are developed
  • Regulatory affairs professionals
  • Project managers
  • CMC/pharmaceutical research professionals
  • Manufacturing Personnel
  • Newly-appointed staff with no previous experience in the pharmaceutical industry
  • Financial managers
  • Brand team personnel
  • Statisticians & data management professionals
  • A pharmaceutical employee who wishes to better their knowledge of drug development

Key Topics Covered:

RAPS - This course has been pre-approved by RAPS as eligible for up to 8 credits towards a participant's RAC recertification upon full completion.

Presenting the overview of drug development products

  • Explanation of product types and directions of administration
  • The comprehensive process of drug development
  • Definition and remedies involved in drug development

View on the global pharmaceutical and drug market

  • Global market shares of biological and chemical drugs
  • Role and responsibilities of professionals in drug development
  • Size and key therapeutic areas
  • Area-wise alterations

Drug discovery

  • Targets of the Drug in development
  • The Anthropological Genome Project
  • Lead compound recognition and optimization


Supervisory submissions

  • Preparation of Common Technical Document
  • CTD components
  • Provincial managerial material
  • The application procedure for biologic and chemical drug products - US and EU


Pre-clinical development

  • In-procedure controls and issue testing
  • Solubility, penetrability, and verbal bioavailability
  • Preparation decisions for refining bioavailability
  • Visual isomerism
  • Polymorph and salt form screening
  • Common formulation types

Clinical research

  • Serious excellence qualities
  • Clinical education design
  • Methodical Increase Facts
  • Adversative incident reporting
  • Influence of mobile calculation on scientific investigate

Pharmacokinetics and toxicity Checks

  • Drug plasma absorption shapes
  • Preoccupation, delivery, absorption, and the abolition of drugs
  • First-pass absorption
  • Types of toxicity screening

Break 15 mins

Post-endorsement alteration

  • Difficulties regarding creation development
  • New ICH Q12 - the promise of relaxed post-sanction change
  • The present or existing situation

US and EU Pharmacovigilance significant fundamentals of rule

  • Drug product creation
  • Delivery
  • ICH direction


Karl M. Nobert
Michael Best & Friedrich LLP

Karl focuses his practice in FDA Regulatory law, representing U.S. and international clients in the food and drug industries with regard to pharmaceuticals and OTC drugs, biologics, medical devices, food and beverages including dairy products, cosmetics, vitamins and dietary supplements, and veterinary products.

He has particular experience in the areas of prescription drugs and regenerative medicine, and has counseled numerous clients seeking FDA approval for Rx drugs and cellular-based products to treat both humans and animals.

For more information about this training visit https://www.researchandmarkets.com/r/vlaof6

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.